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RETINOIC ACID SYNDROME - RADIOLOGICAL FEATURES

The treatment of acute promyelocytic leukemia (APL) with alltrans-retinoic acid (ATRA) sometimes results in a syndrome
characterized by fever, respiratory distress, pleural and pericardial effusion, weight gain, and pulmonary infiltrates on chest
radiography (2). We have recently observed a patient with radiological features suggesting the diagnosis of retinoic acid syndrome, which to our knowledge has not earlier been mentioned
in the radiological literature.
The patient was a 23-year-old woman presenting with fever
and pancytopenia. She was diagnosed as having APL and was
treated with ATRA. On the fifth day of therapy, she became
acutely short of breath. Her respiratory rate was accelerated, her
pulse rate was 160/min, temperature 3 7 T , and blood pressure
140/80 mm Hg. Auscultation of the chest revealed diminished
breath sounds on the left side. A chest radiograph showed alveolar infiltrates on the right side and opacification of the left
hemithorax due to pleural effusion. Analysis of arterial blood
gases revealed marked hypoxemia. She was managed with
mechanical ventilation and 10 mg of dexamethasone twice
daily. A left-sided chest tube was placed for draining off hemorrhagic fluid, with diminution of the pleural effusion. Alveolar
infiltrates persisted at the right lung base. The clinical and radiological signs further improved and there was complete resolution of the pulmonary infiltrates and the effusion by the third
week.
ATRA is a normal constituent of plasma. It is probably
derived physiologically by intracellular oxidation of plasma
retinol that has been absorbed from the intestines (1, 7). When
administered in therapeutic doses it produces the differentiation
of immature neoplastic cells into mature granulocytes (4). Compared with most anitcancer drugs used for treating acute APL,
ATRA is considered highly safe.
However, the retinoic acid syndrome develops in approximately 25% of patients (2). It may occur between the second
day and the third week of treatment. Death may occur from progressive hypoxemia and multiorgan failure. Patients with APL
who present with a high tumor burden or develop leukocytosis
are more likely to suffer from this syndrome (7). Clinically the
situation resembles the capillary leak syndrome, which results
after infusion of cytokines, i.e. interleukin-2 (5). An explanation
as to the pathogenesis is that the drug induces functional maturation and migratory capacity in undifferentiated leukemic cells.
The migration of these cells into the lung tissue could explain
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the respiratory distress (3). Autopsy has displayed extensive
infiltration of myeloid cells in the lung, liver, skin and kidneys
(2). Recently it has been found that ATRA upregulates the
integrin gene on leukocytes which enhances their adherence to
the capillary endothelium and promotes focal endothelial leakage (2,6).
The syndrome is difficult to manage once established.
Hence, early recognition of the syndrome is important. Unexplained dyspnea, weight gain and fever are good indicators. The
radiographic abnormalities are nonspecific and resemble pulmonary edema or infection. The sudden appearance of pleural
effusion may indicate the onset of this ominous condition.
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